Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Platten

Showing results (111-120 of 318) with videos related to

Pageof 32
Sort By:
Acta Neuropathologica|August 2, 2013
ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosisBenedikt Wiestler, David Capper, Tim Holland-Letz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent gliomaAntje Wick, Jörg Felsberg, Joachim P Steinbach, et al.
Journal of Neurology|December 3, 2016
Increasing the sensitivity of MRI for the detection of multiple sclerosis lesions by long axial coverage of the spinal cord: a prospective study in 119 patientsMichael O Breckwoldt, Johann Gradl, Stefan Hähnel, et al.
Journal of Neurology|June 9, 2021
Chronobiology of transient global amnesiaCarolin Hoyer, Kyoko Higashida, Fabio Fabbian, et al.
Iscience|April 20, 2026
Functional segregation of HIF-1α and AhR controls NK cell responsiveness under hypoxiaSebastiano Giorgetta, Francesco Cortopassi, Theodoros Chanis, et al.
Journal of Neuroimmunology|October 5, 2013
Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant gliomaKatharina Ochs, Felix Sahm, Christiane A Opitz, et al.
Multiple Sclerosis and Related Disorders|January 24, 2021
Diffusely appearing white matter in multiple sclerosis: Insights from sodium (<sup>23</sup>Na) MRIClaudia E Weber, Katja Nagel, Anne Ebert, et al.
Oncoimmunology|May 6, 2015
Trial watch: IDO inhibitors in cancer therapyErika Vacchelli, Fernando Aranda, Alexander Eggermont, et al.
Clinical Case Reports|January 19, 2026
Gilteritinib in an Isolated CNS Recurrence of FLT3-ITD Positive AMLLina Susana Silva-Bermudez, Alexander Streuer, Foteini Christodoulou, et al.
Annals of Thoracic Surgery Short Reports|June 17, 2025
Surviving Extracorporeal Membrane Oxygenation Is a Longitudinal Process: Exploring a Survivorship Model to Improve Quality of LifeIslam Hasasna, Bethany Andrew, Paul Rothenberg, et al.
Pageof 32

Showing results (111-120 of 318) with videos related to

Sort By:
Pageof 32
Acta Neuropathologica|August 2, 2013
ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosisBenedikt Wiestler, David Capper, Tim Holland-Letz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent gliomaAntje Wick, Jörg Felsberg, Joachim P Steinbach, et al.
Journal of Neurology|December 3, 2016
Increasing the sensitivity of MRI for the detection of multiple sclerosis lesions by long axial coverage of the spinal cord: a prospective study in 119 patientsMichael O Breckwoldt, Johann Gradl, Stefan Hähnel, et al.
Journal of Neurology|June 9, 2021
Chronobiology of transient global amnesiaCarolin Hoyer, Kyoko Higashida, Fabio Fabbian, et al.
Iscience|April 20, 2026
Functional segregation of HIF-1α and AhR controls NK cell responsiveness under hypoxiaSebastiano Giorgetta, Francesco Cortopassi, Theodoros Chanis, et al.
Journal of Neuroimmunology|October 5, 2013
Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant gliomaKatharina Ochs, Felix Sahm, Christiane A Opitz, et al.
Multiple Sclerosis and Related Disorders|January 24, 2021
Diffusely appearing white matter in multiple sclerosis: Insights from sodium (<sup>23</sup>Na) MRIClaudia E Weber, Katja Nagel, Anne Ebert, et al.
Oncoimmunology|May 6, 2015
Trial watch: IDO inhibitors in cancer therapyErika Vacchelli, Fernando Aranda, Alexander Eggermont, et al.
Clinical Case Reports|January 19, 2026
Gilteritinib in an Isolated CNS Recurrence of FLT3-ITD Positive AMLLina Susana Silva-Bermudez, Alexander Streuer, Foteini Christodoulou, et al.
Annals of Thoracic Surgery Short Reports|June 17, 2025
Surviving Extracorporeal Membrane Oxygenation Is a Longitudinal Process: Exploring a Survivorship Model to Improve Quality of LifeIslam Hasasna, Bethany Andrew, Paul Rothenberg, et al.
Pageof 32